Average Co-Inventor Count = 4.35
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (31 from 1,777 patents)
2. Transtech Pharma, Inc. (2 from 49 patents)
3. Helsinn Therapeutics, Inc. (0 patent)
33 patents:
1. RE45670 - Aryl carbonyl derivatives as therapeutic agents
2. RE45183 - Heteroaryl-ureas and their use as glucokinase activators
3. 8263634 - Heteroaryl-ureas and their use as glucokinase activators
4. 8148413 - N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
5. 8063081 - Aryl carbonyl derivatives as therapeutic agents
6. 7897628 - Aryl carbonyl derivatives as therapeutic agents
7. 7872139 - Heteroaryl-ureas and their use as glucokinase activators
8. 7851636 - Heteroaryl-ureas and their use as glucokinase activators
9. 7812043 - N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
10. 7598391 - Heteroaryl-ureas and their use as glucokinase activators
11. 7576062 - Compounds with growth hormone releasing properties
12. 7541373 - Aryl carbonyl derivatives as therapeutic agents
13. 7541430 - Peptides for use in treating obesity
14. 7384967 - Aryl carbonyl derivatives as therapeutic agents
15. 6939880 - Compounds with growth hormone releasing properties